Evidence map›Paper›PMID 34980255›Full record

ArticleArthritis research & therapy2022

Salivary anti-nuclear antibody (ANA) mirrors serum ANA in systemic lupus erythematosus.

Ting Zhang, Yong Du, Qingqing Wu, Hao Li, Thao Nguyen, Gabriel Gidley, Valeria Duran, Daniel Goldman, Michelle Petri, Chandra Mohan

Abstract read
In one paragraph

Article in Arthritis research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing.International journal of environmental research and public health · 2023
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ting ZhangBiomedical Engineering Department, University of Houston, 3517 Cullen Blvd, Room 2027, TX, Houston, USA.
Yong DuBiomedical Engineering Department, University of Houston, 3517 Cullen Blvd, Room 2027, TX, Houston, USA.
Qingqing WuBiomedical Engineering Department, University of Houston, 3517 Cullen Blvd, Room 2027, TX, Houston, USA.
Hao LiBiomedical Engineering Department, University of Houston, 3517 Cullen Blvd, Room 2027, TX, Houston, USA.
Thao NguyenBiomedical Engineering Department, University of Houston, 3517 Cullen Blvd, Room 2027, TX, Houston, USA.
Gabriel GidleyBiomedical Engineering Department, University of Houston, 3517 Cullen Blvd, Room 2027, TX, Houston, USA.
Valeria DuranBiomedical Engineering Department, University of Houston, 3517 Cullen Blvd, Room 2027, TX, Houston, USA.
Daniel GoldmanDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Michelle PetriDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Chandra MohanBiomedical Engineering Department, University of Houston, 3517 Cullen Blvd, Room 2027, TX, Houston, USA. cmohan@central.uh.edu.ORCID 0000-0001-7896-5740

Funding

Lupus CohortR01AR043727 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 1997 to 2015
$8.2M
Hopkins Lupus CohortR01AR069572 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 2016 to 2020
$3.4M
Salivary biomarkers in SLER21AR072911 · NIAMS · UNIVERSITY OF HOUSTON · PI MOHAN, CHANDRA · 2017 to 2018
$387k
NIAMS NIH HHS R01 AR043727NIAMS NIH HHS R01 AR069572NIAMS NIH HHS R21 AR072911NIH HHS R01-AR-043727NIH HHS R21-AR-072911
6 · The paper itself

Abstract

objectivesTo assay salivary anti-nuclear antibody (ANA) and its isotypes in patients with systemic lupus erythematosus (SLE) and to investigate relevant clinical associations.

methodsSaliva samples were collected from SLE patients and assayed for salivary ANA using immunofluorescence (IF). Isotypes of salivary ANA, including IgG-ANA, IgA-ANA, and IgM-ANA, were quantified using enzyme-linked immunosorbent assay. The correlations between clinical parameters and levels of salivary ANA and isotypes were evaluated.

resultsSalivary ANA IF intensities were significantly higher in SLE patients than in healthy controls, irrespective of SLE patient disease activity, and strongly correlated with serum ANA titers. Salivary ANA was detected in 67.14% of SLE patients and 10.00% of healthy controls (p < 0.001). Among ANA-positive samples, 80.85% exhibited a nuclear ANA pattern, and 42.55% exhibited a cytoplasmic ANA pattern. Salivary IgG-ANA, IgA-ANA, and IgM-ANA levels, as assayed by ELISA, were significantly increased in both active and less active SLE patients compared with healthy controls, and levels of each isotype were significantly correlated with serum ANA titer. Salivary IgM-ANA levels correlated with the physician global assessment (PGA), SLE disease activity index (SLEDAI), and negatively with serum C3 and C4. Salivary IgG-ANA also correlated with erythrocyte sedimentation rate (ESR), SLEDAI, and negatively with serum C3.

conclusionSalivary ANA levels correlate with serum ANA titer, and salivary IgM-ANA and IgG-ANA correlate variably with PGA, SLEDAI, ESR and complement levels. These findings underscore the potential of using salivary ANA and ANA isotypes as surrogates for serum ANA, particularly for future point-of-care applications since saliva is easier to obtain than blood.

Indexed as

Antibodies, AntinuclearLupus Erythematosus, SystemicBlood SedimentationEnzyme-Linked Immunosorbent AssayHumansImmunoglobulin IsotypesAntibodies, AntinuclearImmunoglobulin IsotypesANAIsotypeSalivaSLE

Identifiers

PMID34980255
PMCPMC8721993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.